skip to content
Home

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 

News Subscribe to News

Read more at: IRC researcher highlights potential of metal organic frameworks at UK Porous Materials Conference

IRC researcher highlights potential of metal organic frameworks at UK Porous Materials Conference

22 September 2022

Research Associate at the School of Chemistry, University of Glasgow, and member of the IRC team, Dr Arvin Eskandari , presented a talk about his current research into the drug delivery potential of metal organic frameworks (MOFs) for cancer therapy at the annual meeting of the Royal Society of Chemistry's Porous Materials...

Read more at: Taking a multidisciplinary approach to better target mesothelioma

Taking a multidisciplinary approach to better target mesothelioma

26 July 2022

This month’s Cancer in Sight blog is written by the IRC’s Professor Stefan Marciniak who explains why targeted delivery could be transformative for mesothelioma patients. As Professor of Respiratory Science and a Consultant in Respiratory Medicine at Addenbrooke's Hospital and the Royal Papworth Hospital, Cambridge...

Read more at: IRC hosts seminar on engineered therapeutics to reprogramme the tumour microenvironment

IRC hosts seminar on engineered therapeutics to reprogramme the tumour microenvironment

30 June 2022

The IRC welcomed Professor Dr Jai Prakash, Professor and Chair Engineered Therapeutics, at the Department of Advanced Organ Bioengineering and Therapeutics, TechMed Centre, University of Twente in the Netherlands for an interdisciplinary seminars. Professor Prakash started the seminar by bringing focus to the cellular and...

Read more at: A personal reflection on living with pleural mesothelioma

A personal reflection on living with pleural mesothelioma

27 June 2022

Ahead of Action Mesothelioma Day on 1 July, this month’s Cancer in Sight blog is written by Helen Bone, a 39-year-old mother of three and specialist nurse, who was diagnosed with pleural mesothelioma in August last year. In the blog, Helen shares the shock of her diagnosis: “ My family knew I was having hospital tests but...

Read more at: IRC announces new partnership with the University of Strathclyde

IRC announces new partnership with the University of Strathclyde

19 June 2022

A new partnership with the University of Strathclyde will enable biological testing of lead materials featured in the development of high-capacity vehicles for the targeted delivery of pharmaceutical compounds to enhance drug efficacy in the treatment of pancreatic cancer. Pancreatic cancer, along with mesothelioma and...

Read more at: Cancer Research UK Cambridge Centre presents strategic five-year plan

Cancer Research UK Cambridge Centre presents strategic five-year plan

15 June 2022

A Town Hall meeting presented plans for the next five years of ground-breaking work at Cancer Research UK Cambridge Centre. Having secured £22.5 million from Cancer Research UK, the Cancer Research UK Cambridge Centre (CRUK CC) called a series of Town Hall meetings held at different campuses across the University of...

Read more at: Read the latest Cancer in Sight blog on how effective outreach helps shape diversity in multidisciplinary teams

Read the latest Cancer in Sight blog on how effective outreach helps shape diversity in multidisciplinary teams

29 May 2022

This month’s Cancer in Sight blog by IRC Research Associate Dr Niamh Fox reflects on the benefits of multidisciplinary teams and the importance of outreach for the future of diversity in science. In her blog titled ‘ Spreading the scientific word: how effective outreach helps shape diversity in multidisciplinary teams’ Dr...

Read more at: IRC announce new partnership with University of Liverpool

IRC announce new partnership with University of Liverpool

25 May 2022

The IRC is collaborating with the University of Liverpool where scientists have developed a new preclinical model of mesothelioma to help speed up the journey of therapeutics from lab to clinic. The IRC programme aims to develop new technologies to effectively deliver drugs for the treatment of three hard-to-treat cancers...

Read more at: New paper published in Royal Society of Chemistry’s Nanoscale highlights promise of nanocarriers for drug delivery

New paper published in Royal Society of Chemistry’s Nanoscale highlights promise of nanocarriers for drug delivery

26 April 2022

A paper co-authored by members of the IRC team brings focus to studies assessing the effect of the carrier size of novel polymer nanocarriers on immunocompatibility, viability and uptake into different pancreatic cancer cells. The open access paper appears in the journal Nanoscale published by the Royal Society of...

Read more at: Read the latest Cancer in Sight blog published today

Read the latest Cancer in Sight blog published today

29 March 2022

This month’s Cancer in Sight blog by Dr Ljiljana Fruk, Associate Professor of Bionanotechnology at the University of Cambridge and IRC Investigator, considers the relationship between the fiction and fact of nanotechnology and its potential as part of the IRC to help target hard-to-treat cancers. In the blog titled ‘ From...

Contact Us

For more information on the EPSRC IRC in targeted delivery for hard-to-treat cancers, please contact the Programme Manager, Claire McGlynn

manager@targeted-delivery.cam.ac.uk

Study at Cambridge

About the University

Research at Cambridge